Trupanion (NASDAQ:TRUP – Get Free Report) and Aflac (NYSE:AFL – Get Free Report) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, earnings, dividends and risk.
Profitability
This table compares Trupanion and Aflac’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Trupanion | 1.71% | 6.71% | 2.89% |
| Aflac | 21.24% | 12.82% | 3.30% |
Insider and Institutional Ownership
67.4% of Aflac shares are owned by institutional investors. 5.6% of Trupanion shares are owned by company insiders. Comparatively, 0.8% of Aflac shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Trupanion and Aflac”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Trupanion | $1.44 billion | 1.04 | $19.43 million | $0.61 | 56.52 |
| Aflac | $17.16 billion | 3.67 | $3.65 billion | $6.86 | 18.58 |
Aflac has higher revenue and earnings than Trupanion. Aflac is trading at a lower price-to-earnings ratio than Trupanion, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings and target prices for Trupanion and Aflac, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Trupanion | 0 | 5 | 1 | 0 | 2.17 |
| Aflac | 4 | 8 | 3 | 1 | 2.06 |
Trupanion currently has a consensus price target of $40.00, indicating a potential upside of 16.01%. Aflac has a consensus price target of $118.73, indicating a potential downside of 6.83%. Given Trupanion’s stronger consensus rating and higher possible upside, research analysts plainly believe Trupanion is more favorable than Aflac.
Volatility and Risk
Trupanion has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Comparatively, Aflac has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500.
Summary
Aflac beats Trupanion on 10 of the 15 factors compared between the two stocks.
About Trupanion
Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.
About Aflac
Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
